Literature DB >> 11448568

Parasitic screening of a refugee population in Illinois.

M H Peterson1, M R Konczyk, K Ambrosino, D F Carpenter, J Wilhelm, F E Kocka.   

Abstract

In a one year period in Illinois, 4,695 stool specimens from refugees for parasitologic screening and 733 diarrheal specimens from non-refugees were tested by routine ova and parasite examination- concentration and permanent stained smear. Patients infected with pathogens were as follows: African group (48.9%), Middle Eastern group (56.5%), Southeast Asian group (48.9%), Eastern European group (46.6%), Hispanic group (38.0%) and non-refugee group (20.7%). The study showed differences between the various groups of refugees and the non-refugee group. The need for routine screening of this population was clearly shown.

Entities:  

Mesh:

Year:  2001        PMID: 11448568     DOI: 10.1016/s0732-8893(01)00244-9

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  4 in total

1.  Presumptive treatment and medical screening for parasites in refugees resettling to the United States.

Authors:  William M Stauffer; Paul T Cantey; Susan Montgomery; Leanne Fox; Monica E Parise; Olga Gorbacheva; Michelle Weinberg; Annelise Doney; Lisa Rotz; Martin S Cetron
Journal:  Curr Infect Dis Rep       Date:  2013-06       Impact factor: 3.725

2.  Parasitic stool testing in newly arrived refugees in Calgary, Alta.

Authors:  Giselle DeVetten; Meghan Dirksen; Robert Weaver; Tanvir Turin Chowdhury; Michael William Aucoin
Journal:  Can Fam Physician       Date:  2017-12       Impact factor: 3.275

3.  High prevalence of methicillin-resistant Staphylococcus aureus, Giardia, and Blastocystis in asymptomatic Syrian asylum seekers in Denmark during 2016 through 2018.

Authors:  Andreas Halgreen Eiset; Christen Rune Stensvold; Kurt Fuursted; Henrik Vedel Nielsen; Christian Wejse
Journal:  J Migr Health       Date:  2020-12-05

4.  Intestinal parasites in stool testing among refugees at a primary care clinic in Toronto, Canada.

Authors:  Frank Müller; Shivani Chandra; Isaac I Bogoch; Meb Rashid; Vanessa Redditt
Journal:  BMC Infect Dis       Date:  2022-03-13       Impact factor: 3.090

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.